Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 100%High 0 · 0%

Serious adverse events · patients with rheumatoid arthritis

Tocilizumab 8 mg/kg + MTX/DMARD showed no clear difference in serious Adverse Events compared with placebo + MTX/DMARD (moderate certainty).

1 finding from 1 review

Tocilizumab for rheumatoid arthritis 2010 · Cochrane Headline outcomes only
RR 1.17 [0.83, 1.64]
3 studies · 1961 participants
Moderate